Transcatheter arterial chemoembolization combined with radiofrequency ablation for the treatment of hepatocellular carcinoma

Oncology (Switzerland)

Volumn 84, Issue , 2013, Pages 40-43

  Peng, Zhen Wei ^a,b   Chen, Min Shan ^a  

^a SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

^b SUN YAT SEN UNIVERSITY   (China)

Author keywords

Hepatocellular carcinoma; Radiofrequency ablation; Transcatheter arterial chemoembolization

Indexed keywords

CANCER CENTER; CANCER CONTROL; CANCER PROGNOSIS; CANCER SURGERY; CHEMOEMBOLIZATION; CHINA; CONFERENCE PAPER; EVENT FREE SURVIVAL; HUMAN; LIVER CELL CARCINOMA; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PLEURA EFFUSION; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RADIOFREQUENCY ABLATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECURRENCE FREE SURVIVAL; SURVIVAL RATE; TUMOR GROWTH;

EID: 84874360221     PISSN: 00302414     EISSN: 14230232     Source Type: Journal    
DOI: 10.1159/000345888     Document Type: Conference Paper

References (33)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D: Global cancer statistics. CA Cancer J Clin 2011; 61: 69-90.
2. Bruix J, Llovet JM: HCC surveillance: who is the target population? Hepatology 2003; 37: 507-509.
3. Kudo M: Japan's Successful Model of Nationwide Hepatocellular Carcinoma Surveillance Highlighting the Urgent Need for Global Surveillance. Liver Cancer, in press.
4. Kim DY, Han KH: Epidemiology and surveillance of hepatocellular carcinoma. Liver Cancer 2012; 1: 2-14.
5. Bruix J, Llovet JM: Prognostic prediction and treatment strategy in hepatocellular carcinoma. Hepatology 2002; 35: 519-24.
6. Llovet JM, Burroughs A, Bruix J: Hepatocellular carcinoma. Lancet 2003; 362: 1907-1917.
7. Lin SM, Lin CJ, Lin CC, Hsu CW, Chen YC: Radiofrequency ablation improves prognosis compared with ethanol injection for hepatocellular carcinoma ^ 4 cm. Gastroenterology 2004; 127: 1714-1723.
8. Llovet JM, Bruix J: Systematic review of randomized trials for unresectable hepatocellular carcinoma: chemoembolization improves survival. Hepatology 2003; 37: 429-442.
9. Takayasu K, Arii S, Ikai I, Omata M, Okita K, Ichida T, et al: Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8, 510 patients. Gastroenterology 2006; 131: 461-469.
10. Chen MS, Li JQ, Zheng Y, Guo RP, Liang HH, Zhang YQ, et al: A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma. Ann Surg 2006; 243: 321-328.
11. Hsu C, Liang PC, Morita S, Hu FC, Cheng AL: Perspectives on the design of clinical trials combining transarterial chemoembolization and molecular targeted therapy. Liver Cancer, in press.
12. Liapi E, Geschwind JF: Combination of local transcatheter arterial chemoembolization and systemic anti-angiogenic therapy for unresectable hepatocellular carcinoma. Liver Cancer, in press.
13. Llovet JM, Real MI, Montana X, Planas R, Coll S, Aponte J, et al: Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial. Lancet 2002; 359: 1734-1739.
14. Lo CM, Ngan H, Tso WK, Liu CL, Lam CM, Poon RT, et al: Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma. Hepatology 2002; 35: 1164-1171.
15. Lencioni R: Chemoembolization in patients with hepatocellular carcinoma. Liver Cancer 2012; 1: 41-50.
16. Lin S, Hoffmann K, Schemmer P: Treatment of hepatocellular carcinoma: a systematic review. Liver Cancer, in press.
17. Salvatore V, Bolondi L: Clinical impact of ultrasound-related techniques in the diagnosis of focal liver lesions. Liver Cancer, in press.
18. Chen MS, Zhang YJ, Li JQ: The role of radiofrequency ablation in treating small hepatocellular carcinoma. Chin J Cancer 2007; 26: 449-152.
19. Livraghi T, Meloni F, Di Stasi M, Rolle E, Solbiati L, Tinelli C, et al: Sustained complete response and complications rates after radiofrequency ablation of very early hepatocellular carcinoma in cirrhosis: is resection still the treatment of choice? Hepatology 2008; 47: 82-89.
20. Rossi S, Ravetta V, Rosa L, Ghittoni G, Viera FT, Garbagnati F, et al: Repeated radiofrequency ablation for management of patients with cirrhosis with small hepatocellular carcinomas: a long-term cohort study. Hepatology 2011; 53: 136-147.
21. Rossi S, Garbagnati F, Lencioni R, Allgaier HP, Marchiano A, Fornari F, et al: Percutaneous radio-frequency thermal ablation of nonresectable hepatocellular carcinoma after occlusion of tumor blood supply. Radiology 2000; 217: 119-126.
22. Ganbold U, Kim YH, Cho SB, Kim GM, Chung HH: Combined TACE and RFA treatment of HCC lesion in contact with blood vessels: local recurrence due to heat sink effect. Liver Cancer 2012; 1: 117.
23. Seki T, Wakabayashi M, Nakagawa T, Itho T, Shiro T, Kunieda K, et al: Ultrasonically guided percutaneous microwave coagulation therapy for small hepatocellular carcinoma. Cancer 1994; 74: 817-825.
24. Seki T, Tamai T, Nakagawa T, Imamura M, Nishimura A, Yamashiki N, et al: Combination therapy with transcatheter arterial chemoembolization and percutaneous microwave coagulation therapy for hepatocellular carcinoma. Cancer 2000; 89: 1245-1251.
25. Higuchi T, Kikuchi M, Okazaki M: Hepatocellular carcinoma after transcatheter hepatic arterial embolization: a histopathologic study of 84 resected cases. Cancer 1994; 73: 2259-2267.
26. Nakashima Y, Nakashima O, Hsia CC, Kojiro M, Tabor E: Vascularization of small hepatocellular carcinomas: correlation with differentiation. Liver 1999; 19: 12-18.
27. Shibata T, Isoda H, Hirokawa Y, Arizono S, Shimada K, Togashi K: Small hepatocellular carcinoma: is radiofrequency ablation combined with transcatheter arterial chemoembolization more effective than radiofrequency ablation alone for treatment? Radiology 2009; 252: 905-913.
28. Morimoto M, Numata K, Kondou M, Nozaki A, Morita S, Tanaka K: Midterm outcomes in patients with intermediate-sized hepatocellular carcinoma: a randomized controlled trial for determining the efficacy of radiofrequency ablation combined with transcatheter arterial chemoembolization. Cancer 2010; 116: 5452-5460.
29. Yan S, Xu D, Sun B: Combination of radiofrequency ablation with transarterial chemoembolization for hepatocellular carcinoma: a meta-analysis. Dig Dis Sci 2012; 57: 3026-3031.
30. Wang W, Shi J, Xie WF: Transarterial chemoembolization in combination with percutaneous ablation therapy in unresectable hepatocellular carcinoma: a meta-analysis. Liver Int 2010; 30: 741-749.
31. Shibata T, Maetani Y, Isoda H, Hiraoka M: Radiofrequency ablation for small hepatocellular carcinoma: prospective comparison of internally cooled electrode and expandable electrode. Radiology 2006; 238: 346-353.
32. Schwartz M, Weintraub J: Combined transarterial chemoembolization and radiofrequency ablation for hepatocellular carcinoma. Nat Clin Pract Oncol 2008; 5: 630-631.
33. Peng ZW, Zhang YJ, Chen MS, Xu L, Liang HH, Lin XJ, et al: Radiofrequency ablation with or without transcatheter arterial chemoembolization in the treatment of hepatocellular carcinoma: a prospective randomized trial. J Clin Oncol, in press.